-
Mashup Score: 2
An estimated five million people will either have to get a new Medicare health plan or Part D drug plan as a result of the shifts.
Source: www.wsj.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0Activist Accuses Pfizer of Pressuring Former Executives - 2 month(s) ago
Starboard said a former CEO and CFO had assisted in its activist campaign but then were pressured to express support for the drugmaker.
Source: www.wsj.comCategories: General Medicine News, General NewsTweet-
The fight between Starboard and Pfizer has taken an unusual, bitter turn. Starboard said a former CEO and CFO had assisted in its activist campaign but then were pressured to express support for the drugmaker. https://t.co/SpyBE9QxTB via @WSJ
-
-
Mashup Score: 1
GSK agreed to pay $2.2 billion to 10 plaintiff firms over liability cases related to its discontinued heartburn medicine Zantac allegedly causing cancer.
Source: www.wsj.comCategories: General Medicine News, General HCPsTweet-
GSK Reached Agreements With 10 Plaintiff Firms Over Zantac Litigation https://t.co/UHAcvUc9oG via @WSJ
-
-
Mashup Score: 3Healthcare Premiums Are Soaring Even as Inflation Eases, in Charts - 3 month(s) ago
Back-to-back years of increases in premiums have added to the average family cost, reaching $25,500 this year
Source: www.wsj.comCategories: General Medicine News, General HCPsTweet-
Inflation is easing across much of the economy. For healthcare? Not yet, charts show. https://t.co/VbP9SiHKlp via @WSJ
-
-
Mashup Score: 2
Danco Laboratories is preparing to ask the FDA to approve Mifeprex’s use for managing miscarriages, a move that could make the drug more widely available.
Source: www.wsj.comCategories: General Medicine News, General HCPsTweet-
The company that brought the abortion pill to the U.S. is preparing to ask the FDA to approve the controversial drug’s use for managing miscarriages https://t.co/hoy76THEFT via @WSJ
-
-
Mashup Score: 2
Scientists say we should pay closer attention to the chronic inflammation that can build as we age.
Source: www.wsj.comCategories: General Medicine News, General HCPsTweet-
More research is showing the damage that inflammaging can cause https://t.co/OvGT0q9hIa via @WSJ
-
-
Mashup Score: 6Eli Lilly’s Weight-Loss, Diabetes Drug Shortages Are Over, FDA Says - 3 month(s) ago
The removal of Zepbound and Mounjaro from the regulator’s shortage list could lead to restrictions on pharmacies making custom-made versions.
Source: www.wsj.comCategories: General Medicine News, General HCPsTweet-
Shortages of Eli Lilly’s popular Mounjaro and Zepbound drugs for diabetes and weight loss are over, the FDA says https://t.co/GHNNl57H25 via @WSJ
-
-
Mashup Score: 1Humana Shares Plunge After Changes in Medicare Star Ratings - 3 month(s) ago
The stock slid more than 15% as the health insurer warned that a steep drop in the federal government’s quality ratings of its Medicare plans could hit its 2026 results.
Source: www.wsj.comCategories: General Medicine News, General HCPsTweet-
Humana warned that recent changes in the federal government’s quality ratings of its Medicare plans could hurt its results https://t.co/sfY8aLJ7Ie via @WSJ
-
-
Mashup Score: 1Exclusive | Glenview Capital Plans Push for Changes at CVS - 3 month(s) ago
The hedge fund has taken a large position in the healthcare company, which has seen its shares fall 24% this year to date.
Source: www.wsj.comCategories: General Medicine News, General NewsTweet-
Hedge fund Glenview Capital has taken a position in CVS Health and plans to push for improvements to the operations of the healthcare company, which has seen its shares fall 24% this year to date https://t.co/cqieR9XfE5 via @WSJ
-
-
Mashup Score: 123andMe Board Resigns in New Blow to DNA-Testing Company - 3 month(s) ago
All seven independent directors of DNA-testing company 23andMe resigned, following a protracted negotiation with CEO Anne Wojcicki over her plan to take the company private.
Source: www.wsj.comCategories: General Medicine News, General HCPsTweet-
All seven independent directors of DNA-testing company 23andMe resigned after a negotiation with founder and CEO Anne Wojcicki over her plan to take the company private https://t.co/pYOnzbTqo4 via @WSJ
-
Enrolling in Medicare health-insurance coverage for 2025 will be trickier than usual. Insurers are dumping plans, trimming offerings and raising fees to boost profits and fulfill U.S. requirements. https://t.co/IxPpaRBp7M via @WSJ